Skip to main content

Sluyter, Ronald

Professor

  • Illawarra Health and Medical Research Institute
  • Faculty of Science, Medicine and Health
  • Molecular Horizons
  • School of Chemistry and Molecular Bioscience
  • Head - Immunology and Cell Signalling

Top Publications


Research Overview


  • Ronald Sluyter is Head of the Immunology and Cell Signalling Group. His group explores the roles P2X7 and other purinergic signalling molecules in human and veterinary health and disease including graft-versus-host disease, cancer immunology, motor neurone disease and pain.

Selected Publications


Investigator On


Impact Story


Advisees


  • Graduate Advising Relationship

    Degree Research Title Advisee
    Doctor of Philosophy Characterising the neutrophil response to Group A Streptococcus Williams, Jonathan
    Doctor of Philosophy Investigating the role of host and pathogen factors in group A streptococcal skin infection McEwan, Tahnee
    Doctor of Philosophy The P2X7 Receptor in Inflammation and Disease Cuthbertson, Peter
    Doctor of Philosophy New generation multifunctional nanoceramics for melanoma prevention and therapy Chaki Borras, Marcela
    Doctor of Philosophy Investigations of the Anti-cancer Potential of Bi and Ga Complexes of Nonsteroidal Anti-inflammatory Drugs and Flavonoids. Crapis, Serafina
    Doctor of Philosophy Combination Therapies to Prevent Graft-versus-host Disease. Sligar, Chloe
    Doctor of Philosophy Targeting P2X7 to Prevent Graft-versus-Host Disease Following Donor Stem Cell Transplantation El Hage, Amal

Professional Service Activities


Keywords


  • Blood cancers
  • Cellular immunology
  • Flow cytometry
  • Graft-versus-host disease
  • Motor neurone disease
  • Purinergic signalling
  • Skin and mucosal cancers

Full Name


  • Ronald Sluyter

Mailing Address


  • Room 32.309, IHMRI (Bldg 32)

    University of Wollongong

    Wollongong

    NSW

    2522

    Australia

Web Of Science Researcher Id


  • B-5798-2009

Top Publications


Research Overview


  • Ronald Sluyter is Head of the Immunology and Cell Signalling Group. His group explores the roles P2X7 and other purinergic signalling molecules in human and veterinary health and disease including graft-versus-host disease, cancer immunology, motor neurone disease and pain.

Selected Publications


Investigator On


Impact Story


Advisees


  • Graduate Advising Relationship

    Degree Research Title Advisee
    Doctor of Philosophy Characterising the neutrophil response to Group A Streptococcus Williams, Jonathan
    Doctor of Philosophy Investigating the role of host and pathogen factors in group A streptococcal skin infection McEwan, Tahnee
    Doctor of Philosophy The P2X7 Receptor in Inflammation and Disease Cuthbertson, Peter
    Doctor of Philosophy New generation multifunctional nanoceramics for melanoma prevention and therapy Chaki Borras, Marcela
    Doctor of Philosophy Investigations of the Anti-cancer Potential of Bi and Ga Complexes of Nonsteroidal Anti-inflammatory Drugs and Flavonoids. Crapis, Serafina
    Doctor of Philosophy Combination Therapies to Prevent Graft-versus-host Disease. Sligar, Chloe
    Doctor of Philosophy Targeting P2X7 to Prevent Graft-versus-Host Disease Following Donor Stem Cell Transplantation El Hage, Amal

Professional Service Activities


Keywords


  • Blood cancers
  • Cellular immunology
  • Flow cytometry
  • Graft-versus-host disease
  • Motor neurone disease
  • Purinergic signalling
  • Skin and mucosal cancers

Full Name


  • Ronald Sluyter

Mailing Address


  • Room 32.309, IHMRI (Bldg 32)

    University of Wollongong

    Wollongong

    NSW

    2522

    Australia

Web Of Science Researcher Id


  • B-5798-2009